Coya Therapeutics Ownership | Who Owns Coya Therapeutics?

Overview Forecast RevenueFinancials Chart

Coya Therapeutics Ownership Summary

Coya Therapeutics is owned by 18.48% institutional investors, 14.69% insiders, and 66.83% retail investors. Dme capital management, lp is the largest institutional shareholder, holding 13.96% of COYA shares. Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund, with 2.56% of its assets in Coya Therapeutics shares.

COYA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Coya Therapeutics	18.48%	14.69%	66.83%
Sector	Healthcare Stocks	50.53%	12.40%	37.07%
Industry	Biotech Stocks	48.96%	12.12%	38.92%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Dme capital management, lp	2.34M	13.96%	$9.20M
Aigh capital management	975.40K	5.83%	$3.84M
Vanguard group	899.14K	5.37%	$5.22M
Alyeska investment group	800.00K	4.78%	$3.15M
Prosight management, lp	420.36K	2.51%	$1.66M
Cm management	375.00K	2.24%	$1.48M
Private management group	369.10K	2.21%	$1.45M
Geode capital management	233.40K	1.40%	$919.78K
Marshall wace, llp	225.79K	1.35%	$889.62K
Dauntless investment group	153.02K	0.91%	$872.22K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Cm management	375.00K	1.24%	$1.48M
Dauntless investment group	153.02K	0.55%	$872.22K
Aigh capital management	975.40K	0.52%	$3.84M
Dme capital management, lp	2.34M	0.29%	$9.20M
Prosight management, lp	420.36K	0.27%	$1.66M
Jbf capital	100.01K	0.06%	$394.02K
Prosperity wealth management	23.80K	0.05%	$135.66K
Private management group	369.10K	0.04%	$1.45M
Long corridor asset management	38.77K	0.04%	$152.74K
Prelude capital management	101.33K	0.03%	$399.24K

Top Buyers

Holder	Shares	% Assets	Change
Prosight management, lp	420.36K	0.27%	420.36K
Dme capital management, lp	2.34M	0.29%	309.60K
Vanguard fiduciary trust	139.89K	0.00%	139.89K
Dauntless investment group	153.02K	0.55%	101.93K
Private management group	369.10K	0.04%	88.83K

Top Sellers

Holder	Shares	% Assets	Change
Awm investment company	-	-	-725.00K
Susquehanna group, llp	39.32K	-	-85.52K
683 capital management	-	-	-70.00K
Point72 asset management	-	-	-37.68K
Walleye capital	-	-	-37.06K

New Positions

Holder	Shares	% Assets	Change	Value
Prosight management, lp	420.36K	0.27%	420.36K	$1.66M
Vanguard fiduciary trust	139.89K	0.00%	139.89K	$551.15K
Quadrature capital	19.89K	0.00%	19.89K	$113.79K
Hightower advisors	10.03K	-	10.03K	$39.51K
Bnp paribas arbitrage, snc	8.56K	-	8.56K	$33.74K

Sold Out

Holder	Change
Citigroup	-1.00
Eversource wealth advisors	-76.00
Harbour investments	-172.00
Tower research capital llc (trc)	-1.18K
Key financial	-2.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	22	-62.07%	3,091,478	-61.06%	18	0.82%	14	-70.21%	1	-75.00%
Dec 31, 2025	36	-	5,215,762	9.67%	31	3.85%	27	50.00%	2	-71.43%
Sep 30, 2025	33	-	4,743,229	5.76%	28	3.94%	16	-5.88%	7	-12.50%
Jun 30, 2025	33	26.92%	4,486,560	-3.78%	26	3.45%	17	6.25%	7	75.00%
Mar 31, 2025	26	-	4,662,591	4.94%	27	3.28%	16	-15.79%	4	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Morn Total Stk Mkt Idx Investor	601.12K	2.56%	-
Vanguard Total Stock Mkt Idx Inv	601.12K	2.56%	-
Vanguard MStar Total Stk Mkt Idx Invest	601.12K	2.56%	-
Vanguard Institutional Extnd Mkt Idx Tr	230.49K	0.98%	10.53K
Fidelity Extended Market Index	105.60K	0.45%	-3.04K
Dimensional US Small Cap ETF	75.56K	0.32%	-
iShares Micro-Cap ETF	65.04K	0.28%	-868.00
DFA US Micro Cap I	37.16K	0.16%	11.23K
Fidelity Series Total Market Index	32.36K	0.14%	-1.07K
Blackrock Extended Mkt Fund CF	31.38K	0.13%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 14, 2024	SNYDER DAVID S	Chief Financial Officer	Buy	$12.93K
Nov 13, 2024	Swaminathan Arun	Chief Executive Officer	Buy	$36.80K
Nov 11, 2024	Grossman Fred	Chief Medical Officer	Buy	$19.97K
Nov 11, 2024	Swaminathan Arun	Chief Executive Officer	Buy	$36.69K
Aug 22, 2023	Lee Ann	-	Buy	$3.62K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	-
2026 Q1	-	-
2025 Q3	-	-
2025 Q1	-	-
2024 Q4	4	-

COYA Ownership FAQ

Who Owns Coya Therapeutics?

Coya Therapeutics shareholders are primarily institutional investors at 18.48%, followed by 14.69% insiders and 66.83% retail investors. The average institutional ownership in Coya Therapeutics's industry, Biotech Stocks , is 48.96%, which Coya Therapeutics falls below.

Who owns the most shares of Coya Therapeutics?

Coya Therapeutics’s largest shareholders are Dme capital management, lp (2.34M shares, 13.96%), Aigh capital management (975.4K shares, 5.83%), and Vanguard group (899.14K shares, 5.37%). Together, they hold 25.16% of Coya Therapeutics’s total shares outstanding.

Does Blackrock own Coya Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Coya Therapeutics.

Who is Coya Therapeutics’s biggest shareholder by percentage of total assets invested?

Cm management is Coya Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.24% of its assets in 375K Coya Therapeutics shares, valued at 1.48M$.

Who is the top mutual fund holder of Coya Therapeutics shares?

Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund holder of Coya Therapeutics shares, with 2.56% of its total shares outstanding invested in 601.12K Coya Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools